Welcome to the Radiology Hub, a dedicated educational resource exploring the role of radiology professionals in the detection, interpretation and monitoring of amyloid-related imaging abnormalities (ARIA) in patients receiving anti-amyloid therapies for Alzheimer's disease.
Consistent MRI protocols and reliable interpretation are essential to identifying ARIA, assessing its severity and supporting informed treatment decisions. However, differences in imaging sequences, diagnostic thresholds and reporting practices can introduce variability and uncertainty.
Explore the educational resources below to strengthen your understanding of ARIA imaging, improve consistency in MRI interpretation and support clear communication and coordinated care across the multidisciplinary team.
This activity has been supported by an independent education grant from Lilly. This education program is only available to healthcare professionals globally, excluding the United Kingdom.
